Speaker | Prof. Dr. Konrad Aden
Affiliation | Universitätsklinikum Schleswig-Holstein, Kiel, Germany
Host-microbial interactions as pathophysiological nexus in inflammatory bowel disease
In inflammatory bowel diseases, many patients do not respond to therapy or do not maintain disease control long-term. Precision medicine-based approaches to overcome the “therapeutic ceiling” are urgently needed. Immunometabolism is an important component to the pathophysiology of inflammatory bowel diseases and thus may serve the purpose of contributing to better and more personalized therapy decisions. While several metabolic pathways contribute, the talk puts special emphasis on the metabolism of the essential amino acid tryptophan.
Related videos
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer
Metabolomics as a tool to stratify patients and guide therapeutic decision
Related articles
- Predictive medicine – Transform medicine with metabolomics – part 2 of 5
- N-acetyl-aspartic acid (NAA) – Significant metabolite for brain function, metabolism, and disease
- Preventive medicine – Transform medicine with metabolomics – part 1 of 5
- Citric acid – Key metabolite in energy production, bone health, and disease therapy
- Precision nutrition – Unlocking health through metabolomics